Search Results 521-530 of 17032 for monoclonal antibody
Tumors with high number of mutations may respond well to immunotherapy. Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the ...
Patients may be considered for monoclonal antibody treatment as a preventive measure to reduce the risk of severe illness from COVID-19. The first dose must ...
Bezlotoxumab, a monoclonal antibody against toxin B was recently approved by the Food and Drug Administration for treatment of CDI in patients at high risk ...
... monoclonal immunoglobulin deposits (PGNMID) by assessing improvement in proteinuria at 12 months. ... antibodies to hepatitis B core antigen [anti-HBc] and/or ...
Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects. Goldenberg DM. David M; Morschhauser ...
Myelin oligodendrocyte glycoprotein antibody-associated disease, also known as MOGAD, is a rare inflammatory disease that affects the central nervous system. In ...
Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Acalabrutinib may stop the growth of cancer ...
Although the prognosis for such patients is generally poor, the use of humanized monoclonal anti-HER2 antibodies, such as trastuzumab, has resulted in long ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
... monoclonal antibody infusions. "The pandemic has brought unprecedented challenges," says Christina Zorn, Mayo Clinic's chief administrative officer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.